Anthem Capital Management

Anthem Capital Management is an early stage venture firm that invests in companies in the mid-Atlantic states.

Business Model:

Revenue: $14.8M

Employees: 51-200

Rankings

Detailed Anthem Capital Management Information

Geographic Data

Anthem Capital Management headquarters map

Address: 1414 Key Hwy

City: Baltimore

State: MD

Zip: 21230

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Anthem Capital Management is an early stage venture firm that invests in companies in the mid-Atlantic states. Anthem’s team has accumulated more than 50 years of venture capital experience. They were early venture investors in such companies as Apple Computer, Samna (Lotus’s word processor), Sequoia Software, HealthSouth, Phycor, Corporate Childcare Services, Immunicon and Sensors for Medicine and Sciences. Regional Footprint Anthem invests exclusively in the Mid-Atlantic states and serves this area from offices located in three of the region’s key markets: the Baltimore–Washington corridor, the Greater Philadelphia market, and the Greater Pittsburgh market. Industry Focus Anthem seeks opportunities in IT/telecom and healthcare/life sciences industries. IT investments are most frequently made in enterprise software or network management software companies. Medical investments tend to fall into three categories: medical devices, biotechnology or healthcare. Investment Stage Anthem invests in early to expansion stage opportunities. Typically, our initial investment is made in the Series A or Series B institutional venture capital round. We have led or co-led 80% of the investments we have made, but also will participate in syndicates where appropriate. Investment Size Anthem seeks to invest between $2 million and $4 million in a company from the first private equity round through exit. Typically, our initial investment ranges from $1 million to $2 million

Contact Phone:
+14106251510

Contact Email:

Announced Date Company Transaction Money Raised
10/2003 Qovia Series A 5.5M
9/1999 ScoreBoard Series A 4.2M
7/2000 ScoreBoard Series B 25M
2/2003 Siperian Series B 8.3M
6/2000 Highway To Health Venture Round 14.5M
5/2003 GlycoMimetics Series A 4.3M
1/2008 Siperian Series E 25M
11/2007 RedLasso Series A 6.9M
6/2006 Qovia Series C 0
6/2006 GlycoMimetics Series B 0
6/2014 Senseonics Venture Round 0
8/2004 GlycoMimetics Series A 5.1M
4/2004 Qovia Series B 10.6M
3/2007 Defywire Venture Round 0
4/2005 Defywire Series B 0
3/2004 BioRexis Series B 30M
6/2004 Nucleonics Series B 49.2M
6/2003 Defywire Series A 4.5M
1/1999 Message Pharmaceuticals Venture Round 6.3M
12/2009 GlycoMimetics Series C 0
7/2005 Immune Control Series A 0
10/2008 Echo360 Venture Round 0
3/2006 Triumfant Series B 0
6/2014 Senseonics Venture Round 0
12/2009 GlycoMimetics Series C 0
10/2008 Echo360 Venture Round 0
1/2008 Siperian Series E 0
11/2007 RedLasso Series A 0
3/2007 Defywire Venture Round 0
6/2006 GlycoMimetics Series B 0
6/2006 Qovia Series C 0
3/2006 Triumfant Series B 0
7/2005 Immune Control Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research